Study info

We are published!

Results of the self-blinding microdose study are now published in the scientific journal eLife! You can access the original research paper here (open access) and the journal's press release.

The future of self-blinding

We have a number of plans for the future of self-blinding studies:

  1. We will launch a self-blinding microdose study 2.0 using the mobile platform Mydelica. MyDelica is a science-backed digital psychedelic healthcare solution, addressing mental wellness. Mydelica will launch in April to a limited number of early subscribers, while the next self-blinding microdose study will launch towards the end of the year on the platform.
  2. We will start a lab based version of the study in Q2 of 2021. For this study, we will see participants in person for certain experiments, thus it will be only open to people in / near London. If you live there and interested, you can register your interest by dropping us a mail.
  3. In the medium/long term, we have plans to make a general self-blinding platform, that can be used to run all sorts of self-blinded citizen science experiments. Think CBD oil, nootropics and the like. If you would be interested to contribute to this platform in any capacity, please get in touch.


Email: microdose-study [at] protonmail [dot] com


Study promo video:

Is microdosing placebo? Presentation for potential participants about the self-blinding microdose study